Sanjivani Paranteral

Sanjivani Paranteral

211.75
+1.55
(0.74%)
hide
Key Fundamentals
Add Ratio
Market Cap
258.20 Cr
EPS
6.81
PE Ratio
32.08
Dividend Yield
0.23 %
Industry
Healthcare
52 Week High
396.95
52 Week Low
194.20
PB Ratio
6.18
Debt to Equity
0.10
Forecast For
Actual

Company News

View All News
Caret
positive
Sanjivani Paranteral Limited Shareholders Approve Key Appointments at 31st AGMSep 27, 2025
Sanjivani Paranteral Limited shareholders approved two key appointments at their 31st Annual General Meeting held on September 26, 2025. Mr. Ashwani A. Khemka was re-appointed as Managing Director for a 5-year term from August 1, 2025 to July 31, 2030. Khemka, a BA graduate with over 30 years of pharmaceutical sector experience, is the father of Executive Director Mr. Srivardhan Ashwani Khemka. Additionally, M/s. HD and Associates was appointed as Secretarial Auditor for 5 financial years starting from 2025-26. HD and Associates is an ICSI-Peer Reviewed firm of practicing company secretaries with over five years of experience in Company Law, SEBI Laws, and FEMA Laws. Both appointments were approved through ordinary resolutions passed by company members.
neutral
Sanjivani Paranteral's Independent Director Mrunmai Sarvankar Retires After Completing 5-Year TermSep 19, 2025
Mrunmai Mahendra Sarvankar has retired from her position as Non-Executive Independent Director of Sanjivani Paranteral Limited effective September 19, 2025. Her retirement follows the successful completion of her 5-year tenure on the board. The company has notified BSE Limited of this board change under regulatory disclosure requirements.
positive
Sanjivani Paranteral Limited's Board of Directors appointed Mr. Basant Shrivastava as an Additional Director under the Independent Category, effective September 11, 2025. The appointment is subject to shareholder approval at the upcoming Annual General Meeting. Shrivastava, who holds DIN 02645245, has been appointed for a 5-year term as Non-Executive Independent Director based on the recommendation of the Nomination and Remuneration Committee. He brings over 40 years of pharmaceutical industry experience, with qualifications including M.Sc. (Chemistry) and MBA from Jamnalal Bajaj Institute of Management Studies. Shrivastava has held leadership positions at Johnson & Johnson, Nelson Chemical, and currently serves as Joint Director at Joint Force Pharma Ltd. He is not related to any existing directors of the company.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,679.10
#1 3,98,049.70
38.75
#1 54,729.00
9.71
#1 10,980
-19.84
61.71
6,621.50
1,75,222.50
76.19
9,712.00
18.67
2,191
26.74
72.60
1,577.60
1,26,768.90
23.67
28,409.50
7.12
5,291
9.88
60.63
3,584.30
1,19,599.80
60.49
11,539.40
6.99
1,911
19.91
53.74
1,255.90
1,03,508.80
#1 18.25
33,741.20
16.73
5,725
1.26
48.97
2,476.60
1,01,344.60
53.48
12,744.20
#1 20.90
2,007
-18.14
47.04
987.65
99,073.80
21.09
23,511.00
18.55
4,615
2.60
45.37
1,940.00
89,121.90
23.79
22,909.50
13.74
3,306
#1 51.64
46.82
5,581.50
66,047.70
28.61
13,458.30
3.70
2,216
21.39
63.11
1,101.00
64,254.10
19.04
32,345.60
9.43
3,484
-10.24
50.87
Growth Rate
Revenue Growth
29.87 %
Net Income Growth
30.65 %
Cash Flow Change
215.89 %
ROE
-8.14 %
ROCE
-10.68 %
EBITDA Margin (Avg.)
-7.11 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
15
13
17
19
18
19
18
Expenses
13
11
14
15
15
16
15
EBITDA
2
2
2
3
3
3
3
Operating Profit %
13 %
17 %
14 %
16 %
15 %
14 %
15 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
Profit Before Tax
2
2
2
3
3
3
2
Tax
0
1
1
1
1
1
1
Net Profit
2
1
2
2
2
2
2
EPS in ₹
1.65
1.08
1.47
1.96
1.62
1.84
1.46

Balance Sheet

Balance Sheet
2024
2025
Total Assets
43
78
Fixed Assets
10
21
Current Assets
29
34
Capital Work in Progress
0
19
Investments
0
0
Other Assets
34
38
Total Liabilities
43
78
Current Liabilities
14
32
Non Current Liabilities
2
7
Total Equity
28
40
Reserve & Surplus
14
25
Share Capital
12
12

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
0
1
Investing Activities
-12
-22
Operating Activities
-11
12
Financing Activities
23
11

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
24.63 %
24.63 %
19.85 %
27.35 %
27.35 %
27.35 %
27.35 %
27.35 %
29.88 %
31.70 %
32.34 %
32.34 %
27.67 %
27.67 %
27.67 %
27.67 %
27.67 %
28.87 %
28.87 %
31.20 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
16.50 %
16.50 %
14.23 %
11.89 %
8.16 %
6.01 %
0.00 %
9.70 %
9.36 %
6.25 %
6.25 %
6.15 %
6.15 %
6.03 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
57.77 %
57.62 %
48.92 %
48.31 %
47.84 %
44.65 %
45.08 %
44.82 %
45.73 %
47.25 %
49.09 %
47.12 %
48.46 %
49.98 %
50.67 %
53.90 %
54.08 %
52.43 %
52.60 %
51.01 %
Others
17.61 %
17.75 %
31.23 %
24.33 %
24.80 %
28.00 %
11.07 %
11.33 %
10.16 %
9.16 %
10.42 %
14.53 %
23.87 %
12.65 %
12.31 %
12.18 %
11.99 %
12.54 %
12.38 %
11.76 %
No of Share Holders
4,952
4,911
4,829
5,004
4,974
4,848
4,826
4,845
4,887
4,758
4,500
4,499
4,800
4,911
6,166
6,731
6,618
6,447
6,429
6,307

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
18 Jan 2024 166.50 167.10
24 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Sept 2024 243.50 300.15
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 280.40 265.10
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 326.45 310.15
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 216.15 212.55
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 214.65 216.90
19 Sept 2025 DIVIDEND Dividend
0.50 /share
19 Sept 2025 212.55 239.45
26 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2025 216.90 239.90

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20184 days ago
Announcement under Regulation 30 (LODR)-Dividend UpdatesOct 08, 2025
Closure of Trading WindowSep 29, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 27, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2025
Announcement under Regulation 30 (LODR)-RetirementSep 19, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 11, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated 11Th September 2025Sep 11, 2025
Disclosure Under Regulation 30Sep 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesSep 05, 2025
Intimation Of Record Date/Cut-Off Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Sep 05, 2025
Reg. 34 (1) Annual Report.Sep 03, 2025
Notice Of 31St Annual General MeetingSep 03, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 12, 2025
Statement Of Deviation & Variation For The Quarter Ended 30Th June 2025Aug 12, 2025
Financial Results For The Quarter Ended 30Th June 2025Aug 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 12Th August 2025 Aug 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2025
Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Tuesday 12Th August 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 07, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 21, 2025
Announcement under Regulation 30 (LODR)-Conversion of SecuritiesJul 18, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 18Th July 2025Jul 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Listing Approval For 197394 Equity Shares Issued On Preferential Basis Pursuant To Conversion Of WarrantsJul 05, 2025
Announcement under Regulation 30 (LODR)-AllotmentJul 04, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday04Th July 2025Jul 04, 2025
Closure of Trading WindowJun 24, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)May 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 27, 2025
Results For The Quarter And Year Ended 31St March 2025May 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 27Th May 2025.May 27, 2025
Update on board meetingMay 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Tuesday 27Th May 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 21, 2025
Announcement under Regulation 30 (LODR)-Conversion of SecuritiesMay 19, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday19Th May 2025May 19, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Closure of Trading WindowMar 26, 2025

Technical Indicators

RSI(14)
Neutral
40.82
ATR(14)
Less Volatile
12.58
STOCH(9,6)
Neutral
35.44
STOCH RSI(14)
Neutral
41.26
MACD(12,26)
Bearish
-1.60
ADX(14)
Weak Trend
13.65
UO(9)
Bearish
45.29
ROC(12)
Downtrend And Accelerating
-4.51
WillR(14)
Neutral
-58.80